Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

FDA regulatory approval stories

Nov 10, 2026

Beam Therapeutics base-editing sickle cell therapy succeeds in pivotal trial

Beam Therapeutics announced its base-edited sickle cell therapy met its primary endpoint in a Phase 1/2 clinical trial, potentially positioning it as a third one-time curative therapy for the disease.

Nov 10, 2026·2 sources
00
Nov 2, 2026

Cerus blood-safety system meets primary endpoint in late-stage trial

Cerus Corp announced that red blood cells treated with its blood-safety technology performed as well as conventional red blood cells in patients requiring transfusions in a late-stage study.

Nov 2, 2026·2 sources
00
Oct 29, 2026

Abbott wins FDA approval for Amplatzer Paraclose device to treat heart valve leaks

Abbott received FDA approval for its Amplatzer Paraclose PVL Occluder, the first transcatheter device designed to close paravalvular leaks around surgical replacement heart valves without requiring additional open-heart surgery.

Oct 29, 2026·1 source
00
Oct 20, 2026

FDA approves GSK's hepatitis B drug Hibsago

The FDA approved GSK's hepatitis B drug Hibsago, allowing patients with the liver infection to maintain viral control after stopping long-term treatment. The approval offers a new treatment option for chronic hepatitis B patients.

Oct 20, 2026·2 sources
00
Sep 23, 2026

FDA advisory panel endorses Grail's Galleri multicancer blood test

A U.S. Food and Drug Administration advisory panel voted Wednesday to recommend approval of Grail's Galleri blood test, which screens for more than 50 types of cancer from a single blood sample. Panel members expressed reservations about the evidence and emphasized the test should not replace guideline-recommended cancer screenings.

Sep 23, 2026·10 sources
00
Aug 11, 2026

Manus to resume independent operations as China blocks $2 billion Meta acquisition

Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The collapse highlights regulatory risks facing Chinese entrepreneurs expanding globally.

Aug 11, 2026·4 sources
00

Manus to resume independent operations after China blocks $2 billion Meta acquisition

Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The blocked takeover highlights regulatory risks facing Chinese entrepreneurs expanding globally.

Aug 11, 2026·4 sources
00
Aug 4, 2026

FDA Grants 510(k) Clearance to DeepHealth's AI-Powered Breast Ultrasound Analysis Platform

DeepHealth, a RadNet subsidiary, received FDA 510(k) clearance for an AI platform that automates breast ultrasound lesion detection, characterization according to ACR BI-RADS standards, and report generation. The technology aims to address the time-intensive, operator-dependent nature of ultrasound breast cancer screening.

Aug 4, 2026·7 sources
00
Jul 22, 2026

Johnson & Johnson receives FDA approval for soft tissue surgical robot

After more than a decade of development, J&J's robotic surgery device received FDA marketing authorization, allowing the healthcare conglomerate to enter the competitive surgical robotics market.

Jul 22, 2026·2 sources
00

Top claims

  • ▪Beam Therapeutics plans to submit an approval application for risto-cel to the U.S. Food and Drug Administration as early as the end of 2026
  • ▪Beam Therapeutics announced its base-editing treatment ristoglogene autogetemcel met its primary endpoint of freedom from severe vaso-occlusive crises
  • ▪If approved, risto-cel would enter a sickle cell treatment market that includes approved genetic therapies Casgevy and Lyfgenia, alongside hydroxyurea, l-glutamine, blood transfusions, and stem cell transplants

Subtopics

Drug Policy, Pricing & Approval5Drug Approval and Clinical Trials4AI antitrust & competition2AI startups2Biotech innovation2China tech & industrial strategy2Clinical trial endpoints2Clinical trials2Healthcare technology2Hematology2AGI arms race & geopolitics1AI in healthcare1Antiviral therapy1Biomedical engineering1Blood safety1Cancer & Oncology1Cancer diagnosis1Cardiovascular diseases1China AI regulations1China-United States relations1Chronic disease management1Diagnostic imaging1FDA drug approval1FDA drug approval process1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories